Free Trial

Ameren's (AEE) Buy (B-) Rating Reaffirmed at Weiss Ratings

Ameren logo with Utilities background

Key Points

  • Ameren's stock received a reaffirmed "buy (B-)" rating from Weiss Ratings, indicating strong analyst confidence in the company's performance.
  • Several analysts have increased their target prices for Ameren, with Morgan Stanley raising it to $111 and KeyCorp to $109, reflecting a positive outlook for the stock.
  • Ameren reported significant quarterly earnings growth, with a revenue increase of 31.2% year-over-year, surpassing analyst expectations with a revenue of $2.22 billion.
  • Five stocks to consider instead of Ameren.

Ameren (NYSE:AEE - Get Free Report)'s stock had its "buy (b-)" rating restated by analysts at Weiss Ratings in a report issued on Friday,Weiss Ratings reports.

Other research analysts also recently issued research reports about the company. Morgan Stanley increased their target price on Ameren from $104.00 to $111.00 and gave the stock an "outperform" rating in a report on Wednesday. KeyCorp raised their price target on Ameren from $104.00 to $109.00 and gave the stock an "overweight" rating in a report on Wednesday, October 15th. UBS Group lifted their target price on Ameren from $111.00 to $114.00 and gave the company a "buy" rating in a research note on Friday, July 11th. Finally, Barclays set a $113.00 target price on Ameren in a research note on Tuesday. Seven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $108.63.

Check Out Our Latest Stock Analysis on AEE

Ameren Stock Up 0.2%

NYSE AEE traded up $0.17 during mid-day trading on Friday, reaching $104.50. 342,524 shares of the company's stock traded hands, compared to its average volume of 1,683,900. Ameren has a 1-year low of $85.27 and a 1-year high of $106.73. The company has a fifty day simple moving average of $101.83 and a 200-day simple moving average of $99.03. The company has a current ratio of 0.80, a quick ratio of 0.56 and a debt-to-equity ratio of 1.51. The company has a market cap of $28.26 billion, a price-to-earnings ratio of 22.98, a P/E/G ratio of 2.65 and a beta of 0.49.

Ameren (NYSE:AEE - Get Free Report) last released its earnings results on Thursday, July 31st. The utilities provider reported $1.01 EPS for the quarter, topping analysts' consensus estimates of $1.00 by $0.01. Ameren had a return on equity of 10.38% and a net margin of 14.55%.The company had revenue of $2.22 billion for the quarter, compared to the consensus estimate of $1.82 billion. During the same quarter last year, the business posted $0.97 EPS. Ameren's quarterly revenue was up 31.2% compared to the same quarter last year. Ameren has set its FY 2025 guidance at 4.850-5.050 EPS. As a group, equities research analysts expect that Ameren will post 4.93 EPS for the current year.

Insider Activity at Ameren

In other news, SVP Gwendolyn G. Mizell sold 1,000 shares of the firm's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $101.79, for a total value of $101,790.00. Following the completion of the sale, the senior vice president owned 9,129 shares of the company's stock, valued at $929,240.91. This trade represents a 9.87% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 0.42% of the stock is currently owned by company insiders.

Institutional Trading of Ameren

Institutional investors have recently bought and sold shares of the company. Grantham Mayo Van Otterloo & Co. LLC lifted its position in shares of Ameren by 1.4% in the second quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 7,105 shares of the utilities provider's stock worth $682,000 after buying an additional 100 shares during the last quarter. Crews Bank & Trust lifted its position in shares of Ameren by 6.3% in the second quarter. Crews Bank & Trust now owns 1,728 shares of the utilities provider's stock worth $166,000 after buying an additional 103 shares during the last quarter. Segment Wealth Management LLC lifted its position in shares of Ameren by 3.6% in the third quarter. Segment Wealth Management LLC now owns 2,941 shares of the utilities provider's stock worth $307,000 after buying an additional 103 shares during the last quarter. NewSquare Capital LLC lifted its position in shares of Ameren by 70.9% in the second quarter. NewSquare Capital LLC now owns 258 shares of the utilities provider's stock worth $25,000 after buying an additional 107 shares during the last quarter. Finally, Keb Asset Management LLC lifted its position in shares of Ameren by 0.9% in the third quarter. Keb Asset Management LLC now owns 12,568 shares of the utilities provider's stock worth $1,312,000 after buying an additional 108 shares during the last quarter. Institutional investors and hedge funds own 79.09% of the company's stock.

About Ameren

(Get Free Report)

Ameren Corporation, together with its subsidiaries, operates as a public utility holding company in the United States. The company operates through four segments: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission. It engages in the rate-regulated electric generation, transmission, and distribution activities; and rate-regulated natural gas distribution business.

See Also

Analyst Recommendations for Ameren (NYSE:AEE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ameren Right Now?

Before you consider Ameren, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ameren wasn't on the list.

While Ameren currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.